In addition, the main action of recently developed diabetes drugs such as dipeptidyl peptidase 4 inhibitor and glucagon-like peptide-1 receptor agonist is to induce the secretion of endogenous insulin to lower the plasma glucose level; this study may provide useful insight for determining strategies and policies in the development of drugs with these novel pharmacological mechanisms. The gene discussed is INS; the disease is diabetes mellitus.